Uncategorized
Allegro completes enrollment in Luminate trial stage 2
Allegro Ophthalmics has completed enrollment in the second stage of its DEL MAR phase 2b clinical trial of Luminate for patients with diabetic macular edema, according to a company press release.In the first stage of the DEL MAR monotherapy trial, Luminate, a first-in-class integrin peptide therapy, met its primary and secondary endpoints; in this second stage, combined therapy with anti-VEGF treatment will be evaluated.